http://www.marketwatch.com/story/two-new-trials-of-mercks-keytruda-pembrolizumab-as-monotherapy-and-in-combination-with-chemotherapy-for-first-line-treatment-of-patients-with-advanced-non-small-cell-lung-cancer-to-be-presented-during-presidential-session-at-esmo-2016-2016-09-28

http://www.dailypolitical.com/2016/09/28/merck-co-mrk-stake-increased-by-weatherly-asset-management-l-p.html
http://www.webbreakingnews.com/2016/09/28/merck-co-mrk-stake-maintained-by-interocean-capital-llc.html
http://www.finanznachrichten.de/nachrichten-2016-09/38707205-updated-phase-1-data-reinforce-the-clinical-profile-of-epacadostat-in-combination-with-keytruda-pembrolizumab-004.htm
http://investingnews.com/daily/life-science-investing/pharmaceutical-investing/merck-new-research-hard-to-treat-cancers/
http://www.presseportal.de/pm/6873/3441853
http://www.prnewswire.com/news-releases/merck-to-present-new-research-focused-on-hard-to-treat-cancers-at-esmo-2016-595056921.html
http://www.perssupport.nl/persbericht/101945/merck-to-present-new-research-focused-on-hard-to-treat-cancers-at-esmo-2016
http://www.europapress.es/comunicados/internacional-00907/noticia-comunicado-merck-to-present-new-research-focused-on-hard-to-treat-cancers-at-esmo-2016-20160928082743.html
http://www.ots.at/presseaussendung/OTE_20160928_OTE0001/merck-to-present-new-research-focused-on-hard-to-treat-cancers-at-esmo-2016
http://www.4-traders.com//MERCK-KGAA-436395/news/Merck-to-Present-New-Research-Focused-on-Hard-to-Treat-Cancers-at-ESMO-2016-23124648/
http://guardian.ng/news/german-firm-re-launches-drugs-to-manage-diabetes-in-nigeria/
http://www.4-traders.com//XENON-PHARMACEUTICALS-INC-18411162/news/Xenon-Pharmaceuticals-Appoints-Dawn-Svoronos-to-Its-Board-of-Directors-23123211/
http://www.dailypolitical.com/2016/09/27/merck-co-mrk-is-boston-partners-4th-largest-position.html
http://www.cnbc.com/2016/09/27/mylan-ceos-testimony-was-a-huge-blow-to-the-entire-pharma-industry-commentary.html
http://allafrica.com/stories/201609270695.html
http://www.thecitizen.co.tz/oped/Shortage-of-drugs-in-govt-facilities-must-be-checked/1840568-3396108-yo80od/index.html

http://www.livemint.com/Companies/er2nDmi22TYZNylmizZ4xH/Hilleman-Lab-scouts-for-partners-to-launch-rotavirus-vaccine.html
http://www.adnkronos.com/immediapress/pr-newswire/2016/09/28/merck-present-new-research-focused-hard-treat-cancers-esmo_2c25Ky1NYAY7yqQyajr6JN.html
http://www.europapress.es/comunicados/internacional-00907/noticia-comunicado-merck-to-present-new-research-focused-on-hard-to-treat-cancers-at-esmo-2016-20160928082739.html
http://www.fool.com/investing/2016/09/27/eli-lilly-stock-upgraded-what-you-need-to-know.aspx?source=eptfxblnk0000004&utm_campaign=article&utm_medium=feed&utm_source=foxbusiness
http://www.wgmd.com/eli-lilly-stock-upgraded-what-you-need-to-know/
http://www.manufacturingchemist.com/news/article_page/Mercks_Viresolve_Pro_Shield_H_virus_filter_removes_protein_aggregates_and_other_impurities/121500

http://www.rttnews.com/2697190/incyte-corp-incy-has-risen-to-over-an-8-month-high-on-study-results.aspx
http://www.finanznachrichten.de/nachrichten-2016-09/38704749-bayer-announces-enrollment-of-first-patient-in-vericiguat-phase-iii-study-020.htm
http://www.perssupport.nl/persbericht/101951/zostavax-r-shingles-vaccine-wins-uk-tender-renewal
http://www.bizjournals.com/sanfrancisco/blog/biotech/2016/09/astrazeneca-azn-hcp-mrk-cove-at-oyster-point.html
http://animal.agwired.com/2016/09/27/merck-animal-health-beef-sustainability-calculator-app/
http://www.fool.com/investing/2016/09/27/pfizers-latest-immunotherapy-deal-could-be-great-n.aspx?source=eptfxblnk0000004&utm_campaign=article&utm_medium=feed&utm_source=foxbusiness
http://www.wgmd.com/pfizer039s-latest-immunotherapy-deal-could-be-great-news-for-this-tiny-company/
http://www.proactiveinvestors.co.uk/companies/news/166523/maxcyte-revenues-climb-as-big-pharma-seeks-next-generation-of-drugs-166523.html
http://www.sunstar.com.ph/pampanga/local-news/2016/09/27/angeleno-elderlies-get-free-anti-pneumonia-vaccination-500142
http://www.marketwatch.com/story/alnylam-reports-positive-initial-results-from-ongoing-phase-12-study-of-aln-go1-an-investigational-rnai-therapeutic-for-the-treatment-of-primary-hyperoxaluria-type-1-2016-09-24
https://consumerist.com/2016/09/28/senators-ask-doj-to-investigate-mylan-over-possible-epipen-medicaid-fraud/
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/ciplaaims-to-reach-1bnindia-sales-through-tie-ups/articleshow/54554830.cms
http://www.irishsun.com/index.php/sid/248057807
http://www.finanznachrichten.de/nachrichten-2016-09/38700700-global-cancer-immunotherapy-market-worth-dollar-119-39-billion-by-2021-rising-healthcare-expenditure-driving-growth-research-and-markets-004.htm
http://www.4-traders.com//news/Global-Alzheimer-s-Therapeutics-Market-Analysis-2016-Forecast-to-2022-Research-and-Markets--23122854/
http://www.marketwatch.com/story/the-fourth-annual-bionj-ceo-summit-took-it-over-the-top-2016-09-27
http://www.prnewswire.com/news-releases/the-galien-foundation-announces-discovery-of-the-decade-award-nominees-in-best-pharmaceutical-product-best-biotechnology-product-and-best-medical-technology-categories-300334443.html
http://www.themalaymailonline.com/tech-gadgets/article/apple-said-to-expand-healthkit-from-tracker-to-diagnosis-tool1
https://euagenda.eu/events/2016/11/16/ici-europe
http://www.prnewswire.co.uk/news-releases/zostavax-shingles-vaccine-wins-uk-tender-renewal-595058331.html
http://triblive.com/business/johndorfman/11207160-74/billion-avoid-buy
